Abstract
Nowadays, the domains of life-respecting, therapeutic polymeric systems and materials are among the most attractive areas in polymer science. Increasing attention is being paid to polymeric compounds that can be bioassimilated, especially in the field of time-limited therapeutic applications. Basically biopolymers are of interest because of their inherent biodegradability. However, a close look at the requirements to be fulfilled show that only a few of them can be used in the human body. The interest and the strategy to make artificial biopolymers, i.e. polymers of non-natural origin that are made of prometabolite building blocks and that can serve as components of biomedical or pharmacological therapeutic systems, are recalled. A few examples of artificial biopolymers for biomedical applications are presented.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Vert, M., 1986, Polyvalent polymeric drug caniers, In “CRC Critical Reviews -Therapeutic Drug Carrier Systems”, (S.D. Bruck Ed.), CRC Press, Boca Raton, 2: 291–327
Vert, M., 1987, Design and synthesis of bioresorbable polymers for controlled release of drugs, in “Controlled release of drugs from polymeri particles and Macromolecules”, (S.S. Davis & L. Illum Eds), Wright IOP Publ. Ltd., Bristol, p.117–125
Hoenich, N. A., and Stamp, S., 2000, Clinical investigation of the role of membrane structure on blood contact and solute transport characteristics of a cellulose membrane, Biomaterials 21: 317–324
Draget, K. I., Skjak-Braek, G., and Smidsrod, O., 1994, Alginic acid gels: Effects of alginate chemical composition and molecular weights, Carbohydr. Polym. 25: 31–38
Qin, Y., and Gilding, R. K., 1996, Alginate fibers and wound dressings, Medic. Device Technol. 7: 32–41
Mishler, J. M., 1984, Synthetic plasma volume expanders — their pharmacology, safety and clinical efficacy, Clinics in Haematol. 13: 75–92
Muzzarelli, R. A. A., 1993, Biochemical significance of exogenous chitin and chitosan in animals and patients, Carbohydr. Polym. 20: 7–16
Davidson, J. M., Nanney, L. B., Broadley, K. N., Whitsett, J. S., Aquino, A. M., Beccaro, M., and Rastrelli, A., 1990, Hyaluronate derivatives and their application to wound healing : Preliminary observations, in Polymer in Medicine — 4, (C. Migliaresi, E. Chiellini, P. Giusti and L. Nicolais Eds.), Elsevier Applied Science, London, p.171–177
Bourzeix, K., 2000, Biomatériaux articulaires injectables, in “Actualités en Biomatériaux”, (D. Mainard et al., eds.), Editions Romillat, Paris, p.141–146
Lee, S. Y., 1996, Bacterial polyhydroxyalkanoates, Biotech. Bioeng. 49: 1–14
Lenz, R. W., 1993, Biodegradable Polymers, Adv. Polym. Sci. 107: 1–40
Marois, Y., Zhang, Z., Vert, M., Deng, X., Lenz, R. and Guidoin, R., 1999, Mechanism and rate of degradation of polyhydroxyoctanoate films in aqueous media : a long term study, J. Biomed. Mater. Res. 49: 216–224
Parkany, M., 1984, Polymers of natural origin as biomaterials. 2. Collagen and gelatin, in Macromolecular Biomaterials, (G.W. Hastings and P. Ducheyne Eds.), CRC Press, Boca Raton, p. 111–118
Casagranda, F., Ellender, G., Werkmeister, J. A., and Ramshaw, J. A. M., 1994, Evaluation of alternative glutaraldehyde stabilization strategies for collagenous biomaterials, J. Mater. Sci. : Mater. In Med. 5: 332–337
Martinowitz, U., Spotnitz, W. D., and De-Gaetano, G.,1997, Fibrin tissues adhesives. 1997 State of the art, Thromb. Haemost. 78: 661–666
Burnouf-Radosewich, M., Burnouf, T., and Huart, J.J., 1990, Biochemical and physical properties of a solvent-detergent-treated fibrin glue, Vox Sang. 58: 77–84
Park, M. S., and Cha, C. A., 1993, Biochemical aspects of autologous fibrin glue derived from ammonium sulfate precipitation, Laryngoscope 103: 193–196
G. Kerényi, 1984, Polymers of natural origin as biomaterials. 1. Fibrin in Macromolecular Biomaterials, (G.W. Hastings and P. Ducheyne Eds.), CRC Press, Boca Raton, p. 91–110
Li, S.M., and Vert, M., 1995, Biodegradation of aliphatic polyesters, in “Degradable Polymers: Principles and Applications”, (G. Scott and D. Gilead Eds.), Chapman & Hall, London, p. 43–87
Athanasiou, K. A., Agrawal, C. M., Barber, F. A., and Burkhart, S. S., 1998, Orthopaedic applications for PLA-PGA biodegradablme polymers, Arthroscopy 4; 726–737
Marcincinova-Benabdillah, K., Coudane, J., Boustta, M., Engel, R., and Vert, M., 1999, Synthesis and characterization of novel degradable polyesters derived from D-gluconic and glycolic acids, Macromolecules 32: 8774–8780
Braud, C., and Vert, M., 1993, Poly(ß-malic acid) based biodegradable polyesters aimed at pharmacological uses, Trends in Polym. Sci. 3: 57–65
Vert, M., 1998, Chemical routes to poly(ß-malic acid) and potential applications of this water soluble bioresorbable poly(ß-hydroxy alkanoate), Polym. Degrad. And Stab. 59: 169–175
Cammas, S., Guérin, Ph., Girault, J. P., Holler, E., Gache, Y., Vert, M., 1993, Natural poly(L-malic acid): NMR shows a poly(3-hydroxy acid)-type structure, Macromolecules 28: 4681–4684.
Fischer, H., Erdmann, S., Holler, E., 1989, An unusual polyanion from Physarum polycephalum that inhibits homologous DNA polymerase a in vitro, Biochemistry 28: 5219–5226.
Boustta, M., Huguet, J., and Vert, M., 1991, New functional polyamides derived from citric acid and L-lysine: Synthesis and characterization, Makromol. Chem., Macromol. Symp., 47: 345–355
Henin, O., Boustta, M., Coudane, J., Domurado, M., Domurado, D., and Vert, M., 1998, Covalent binding of mannosyl ligand via 6-O position and glycolic arm to target a PLCA-type degradable drug carrier toward macrophages, J. Bioact. Comp. Polym. 13 19–32
Abdellaoui, K., Boustta, M., Morjani, H., Manfait, M. and Vert, M., 1998, Metabolitederived artificial polymers designed for drug targeting, cell penetration and bioresorption, Europ. J. Pharm. Sci. 6: 61–73
Gautier, S., Boustta, M., and Vert, M., 1997, Poly(L-lysine citramide), a water soluble bioresorbable carrier for drug delivery : Aqueous solution properties of hydrophobized derivatives, J. Bioact. Comp. Polym. 12: 77–98
Rossignol, H., Boustta, M. Vert, 1999, Synthetic poly(ß-hydroxyalkanoates) with carboxylic acid or primary amine pendent groups and their complexes, Intern. J. Biol. Macromol. 25: 255–264
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Vert, M. (2001). Biopolymers and Artificial Biopolymers in Biomedical Applications, an Overview. In: Chiellini, E., Gil, H., Braunegg, G., Buchert, J., Gatenholm, P., van der Zee, M. (eds) Biorelated Polymers. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-3374-7_6
Download citation
DOI: https://doi.org/10.1007/978-1-4757-3374-7_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4419-3369-0
Online ISBN: 978-1-4757-3374-7
eBook Packages: Springer Book Archive